Inventor · disambiguated record
Hunter Chen
Also filed as: CHEN HUNTER · CHEN HUNTER H
25 granted patents·15 pending applications·106 citations·filing 2002–2025
96Inventor score
Top patents by PatentIndex Score
40 records- 0198US12012445B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Jun 18, 2024·4 cites·30 claims
- 0298US11958894B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Apr 16, 2024·5 cites·30 claims
- 0398US11732025B2Anti-VEGF protein compositions and methods for producing the sameREGENERAN PHARMACEUTICALS INC·Filed 2022·Granted Aug 22, 2023·11 cites·30 claims
- 0498US11548932B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Jan 10, 2023·8 cites·30 claims
- 0598US11542317B1Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Jan 3, 2023·11 cites·30 claims
- 0698US11505593B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Nov 22, 2022·13 cites·29 claims
- 0798US11485770B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Nov 1, 2022·6 cites·14 claims
- 0898US11306135B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Apr 19, 2022·7 cites·16 claims
- 0998US11186625B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Nov 30, 2021·10 cites·3 claims
- 1097US12054532B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Aug 6, 2024·2 cites·30 claims
- 1197US12012444B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Jun 18, 2024·2 cites·19 claims
- 1297US11753459B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Sep 12, 2023·5 cites·30 claims
- 1394US12338274B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Granted Jun 24, 2025·0 cites·30 claims
- 1494US12319728B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Granted Jun 3, 2025·0 cites·30 claims
- 1593US2024294606A1Anti-vegf protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1688US11291636B2Polymer protein microparticlesREGENERON PHARMA·Filed 2017·Granted Apr 5, 2022·2 cites·22 claims
- 1788US7324316B2Hot-swap circuit system for fan tray moduleDELTA ELECTRONICS INC·Filed 2005·Granted Jan 29, 2008·18 cites·20 claims
- 1886US2025289868A1Anti-vegf protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1984US11835527B2Deglycosylation methods for electrophoresis of glycosylated proteinsREGENERON PHARMA·Filed 2021·Granted Dec 5, 2023·1 cites·31 claims
- 2084US2024207194A1Polymer protein microparticlesREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2181US12480955B2Deglycosylation methods for electrophoresis of glycosylated proteinsREGENERON PHARMA·Filed 2023·Granted Nov 25, 2025·0 cites·26 claims
- 2279US11951216B2Polymer protein microparticlesREGENERON PHARMA·Filed 2022·Granted Apr 9, 2024·0 cites·20 claims
- 2375US11559489B2Tuning of release kinetics in hydrogelsREGENERON PHARMA·Filed 2019·Granted Jan 24, 2023·1 cites·32 claims
- 2474US2023414716A1Sustained release formulations using non-aqueous emulsionsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2571US2024316195A1High concentration protein formulationREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2670US2025295590A1Fabrication of protein-encapsulating microgelsREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 2769US12350374B2Fabrication of protein-encapsulating microgelsREGENERON PHARMA·Filed 2021·Granted Jul 8, 2025·0 cites·17 claims
- 2869US12239687B2Sustained release formulations using non-aqueous membrane emulsificationREGENERON PHARMA·Filed 2021·Granted Mar 4, 2025·0 cites·20 claims
- 2969US2025179177A1Stable antibody formulationREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 3068US12036280B2High concentration protein formulationREGENERON PHARMA·Filed 2019·Granted Jul 16, 2024·0 cites·15 claims
- 3168US11730793B2Sustained release formulations using non-aqueous emulsionsREGENERON PHARMA·Filed 2020·Granted Aug 22, 2023·0 cites·9 claims
- 3266US12396952B2Tuning of release kinetics in hydrogelsREGENERON PHARMA·Filed 2023·Granted Aug 26, 2025·0 cites·19 claims
- 3366US2013129830A1Polymer Protein MicroparticlesREGENERON PHARMA·Filed 2012·Application pending·0 cites
- 3462US2024352103A1Anti-fel d1 antibody formulationsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 3561US2025235505A1Sustained release formulations using non-aqueous membrane emulsificationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 3645US2020022917A1Compositions and methods of manufacturing protein microparticlesREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 3740US2018289623A1Stable protein compositionsREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 3839US2006005264A1Computer security systemLIN H M C·Filed 2004·Application pending·0 cites
- 3939US2003064025A1Imaging systems for in vivo protocolsFiled 2002·Application pending·0 cites
- 4038US2003106832A1Carrier tape for an integrated circuit deviceFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hunter Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →